European Blood and Blood Components Market size to exceed $5bn by 2024

European Blood and Blood Components Market size is set to exceed USD 5.0 billion by 2024; according to a new research study published by Global Market Insights, Inc.
 

Increasing risk of infection resulting from transfusion of blood and blood components along with decreasing number of blood donations will decrease Europe blood and blood components market size during the forecast years. As per forecasts, transfusion of red blood cells will decrease from 15.7 million units in 2013 to 13.9 million units by 2024.

 

Request Sample Buy NowInquiry Before Buying

 

Increasing number of surgeries and other treatments such as chemotherapy requiring external supply to blood and blood components will sustain the market demand over the forecast timeframe. Furthermore, growing number of cosmetic procedures utilizing blood components will positively impact blood components market. However, programmes such as ‘optimal use of blood’ to reduce wastage of blood and blood components along with declining number of blood donations will diminish the market size to certain extent over the coming years.
 

UK Blood and Blood Components Market, By Product, 2017 & 2024 (USD Million)
European Blood and Blood Components Market

Get more details on this report - Request Free Sample PDF
 

Browse key industry insights spread across 103 pages with 122 market data tables & 8 figures & charts from the report, “Europe Blood and Blood Components Market Size By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By Application (Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By End-Use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Country Outlook (Germany, UK, France, Spain, Italy, Russia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/europe-blood-and-blood-components-market

 

Blood components segment dominated the industry in 2017 and is estimated to reach USD 3.9 billion by 2024. According to the estimates, transfusion of blood components will reduce from 21.9 million units in 2013 to 18.9 million units by 2024. Rising awareness about efficient use of blood and blood components, growing application of blood components in aesthetic procedures and treatments such as chemotherapy will sustain the demand for blood components market over the forecast period.
 

Trauma and surgery application segment accounted for over 40% market share in 2017. Increasing number of injuries and surgical procedures will stimulate demand for blood and blood components over the coming years. Massive blood transfusion necessary in majority of trauma cases will drive segmental growth.
 

Based on end-use, the industry is bifurcated into hospitals, ambulatory surgical centers and others. Ambulatory surgical centers is anticipated to reach USD 1.5 billion by 2024 owing to improved outcomes delivered at outpatient surgical facilities at less cost as compared to hospitals.
 

Russia blood and blood components market is estimated to witness fastest growth to reach USD 840 million by 2024. Growing geriatric population base prone to suffer from various chronic diseases and high number of surgical procedures should upsurge the demand for blood transfusion. Moreover, rising number of initiatives to motivate the population to donate blood will propel Russia blood and blood components market growth.
 

Inquiry Before BuyingRequest Sample
 

Europe blood and blood components market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:
 

European Blood and Blood Components Market by Product, 2013-2024 (USD Million)

  • Whole blood
  • Blood components
    • Red Blood CellsRemove Anchor
    • Platelets
    • Plasma
    • White Blood Cells

European Blood and Blood Components Market by Application, 2013-2024 (USD Million)

  • Anemia
  • Trauma & Surgery
  • Cancer Treatment
  • Bleeding Disorders
  • Others

European Blood and Blood Components Market by End-use, 2013-2024 (USD Million)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions/countries:

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia

 

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X